Home › Funds › Vestal Point Capital, LP › REGN
Vestal Point Capital, LP position in REGN
REGENERON PHARMACEUTICALS · Health Care
Vestal Point Capital, LP reported holding 40,000 shares of REGN (REGENERON PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$24.9M, representing 0.58% of its reported portfolio and ranking #41 among its reported holdings. Vestal Point Capital, LP has disclosed REGN holdings in 5 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Vestal Point Capital, LP's REGN position evolved
Vestal Point Capital, LP first disclosed a stake in REGN in Q4 2023 at 10,000 shares (US$8.8M). The position peaked in Q1 2026 at 40,000 shares, worth US$30.9M. Across 5 filings, Vestal Point Capital, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 40,000 shares valued at US$24.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 10.00K | $8.78M | New |
| Q4 2024 | 20.00K | $14.25M | New |
| Q3 2025 | 25.00K | $14.06M | New |
| Q1 2026 | 40.00K | $30.91M | New |
| Q2 2026 | 40.00K | $24.94M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- LOOMIS SAYLES & CO L P 1.86M sh · $1.16B · Q2 2026
More on Vestal Point Capital, LP
FAQ
How long has Vestal Point Capital, LP held REGN?
Vestal Point Capital, LP has disclosed REGN holdings in 5 of the last 11 reported quarters, going back to Q4 2023.
What is Vestal Point Capital, LP's current position in REGN?
As of Q2 2026, Vestal Point Capital, LP holds 40.00K shares of REGN (REGENERON PHARMACEUTICALS), valued at $24.94M, representing 0.58% of its reported portfolio and ranking #41.
Has Vestal Point Capital, LP been buying or selling REGN?
In the latest 13F filing (Q2 2026), Vestal Point Capital, LP held unchanged its position in REGN. The position peaked in Q1 2026 at 40.00K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.